We’re Changing The Rules On Cancer
We have created a collaborative powerhouse as adaptive and multiform as cancer itself––audacious, evolving, unconventional––at the center of a world-renowned university and medical center. This is how we’re changing the rules on cancer.
Critical Mass of Talent
At Duke we know something about building great teams. Rising stars and renowned leaders alike come here to join DCI’s global front-runners in science, medicine and technology. We recruit and encourage these tenacious investigators and physicians with an ethos of original thinking and collaboration to accelerate and expand their pioneering work.
We take the road less traveled to find breakthrough discoveries. Inspired by the bravery of our patients, we have become unafraid to pursue even outrageous possibilities. Is the risk higher? Yes. And sometimes we fall short. But when we succeed, we give the world the kind of breakthroughs that don’t always occur in other laboratories.
We are moving further, faster and with greater purpose. We draw from Duke’s entire pool of world-class talent and resources to create non-linear exchanges of knowledge and innovation. By doing so, we exponentially increase the probability of advances to transform cancer prevention, treatments and survivorship.
Integrated Patient Care
A ground-breaking model for patient care is being fostered here. We organized our flagship cancer center to assemble each patient’s entire clinical team and treatment resources in a single state-of-the-art facility. With a total integration of clinical research, treatment and support services to deliver cancer care as it should be.
The Duke Cancer Institute Blog provides faculty and staff with new updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. Followers are invited to submit updates, story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.
Pictured: Mattias Gromeier, MD, Associate Professor of Neurosurgery and lead researcher for the poliovirus vaccine trial.
Photo by Shawn Rocco, Duke Health Marketing